findmyKOL
Clinical trialNCT01410318Active, not recruitingObservational

Progression of Early Subclinical Atherosclerosis

SponsorFundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIEnrollment4,184Atherosclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Agustin Mocoroa, MD

    Banco Santander

    Study Chair
  • Ana Dopazo, PhD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Chair
  • Antonio I Fernández Ortiz, PhD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Director
  • Beatriz Lopez Melgar, MD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Chair
  • Borja Ibañez, PhD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Chair
  • Ginés Sanz, PhD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Chair
  • Jose Luis Peñalvo, PhD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Chair
  • Jose María Ordovás, PhD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Chair
  • Leticia Fernández Friera, PhD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Chair
  • Luis Jesús Jiménez Borreguero, MD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Chair
  • Martín Laclaustra, PhD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Study Chair
  • Valentín Fuster, PhD

    Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Ciudad Financiera del Grupo Santander

    Boadilla del Monte, Madrid, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Jun 2010
Primary completion
30 Jun 2030
Completion
30 Jun 2030
Last update posted
29 Apr 2021
Registered enrollment
4,184
Registry id
NCT01410318

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.